ストックスクリーナーアプリを入手
1.95
14.71%
0.25
プレマーケット:
2.00
0.05
+2.56%
前日終値:
$1.70
開ける：
$1.74
24時間の取引高:
749.56K
Relative Volume:
5.20
時価総額：
$9.37M
収益：
$3.19M
当期純損益:
$-10.42M
株価収益率:
-0.055
EPS:
-35.4757
ネットキャッシュフロー:
$-10.65M
1週間 パフォーマンス:
+23.42%
1か月 パフォーマンス:
+33.56%
6か月 パフォーマンス:
+61.16%
1年 パフォーマンス:
-36.07%
1日の値動き範囲:
$1.70
$2.05
1週間の範囲:
$1.60
$2.05
52週間の値動き範囲:
$1.00
$11.70
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
INBS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
1.95 | 9.37M | 3.19M | -10.42M | -10.65M | -35.48 |
|
ABT
Abbott Laboratories
|
128.22 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.02 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
396.07 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
70.99 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Intelligent Bio Solutions Inc (INBS) 最新ニュース
EXCLUSIVE: Intelligent Bio Solutions Expects To Record Increased Profitability In Q2 On Higher-Margin Sales - AOL
Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales - The Manila Times
Q2 Earnings: This Medical Device Company Just Doubled Its Profit Margins with Recurring Revenue - StockTitan
Iveda Solutions, Inc. (NASDAQ:IVDAW) Sees Significant Increase in Short Interest - Defense World
Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Down 5.1% in January - Defense World
INBS drug screening system to support multiple languages By Investing.com - Investing.com Australia
Fingerprinting Drug Screening Systems - Trend Hunter
Intelligent Bio Solutions Expands Fingerprinting System Globally - TipRanks
Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade - Marketscreener.com
INBS drug screening system to support multiple languages - Investing.com
Revolutionary Fingerprint Drug Test Goes Global: Multi-Language Update Opens Door to 4 Billion Users - StockTitan
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029 - GlobeNewswire
Intelligent Bio Solutions Expands with UK Partnership - TipRanks
Intelligent Bio Solutions Partners With Quantum Traffic Management To Enhance Drug Screening - Nasdaq
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing - The Manila Times
Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug - EIN News
EXCLUSIVE: Intelligent Bio Solutions Partners With UK-Based Quantum TM For Fingerprint Drug Testing At 10 Sites - AOL
Revolutionary Fingerprint Drug Test Wins Major UK Contract, US Launch Next - StockTitan
Intelligent Bio Solutions Partners with IVY Diagnostics - TipRanks
EXCLUSIVE: Intelligent Bio Solutions Partners With IVY Diagnostics, Seeks Expansion In Europe's $3.6 Billion Drug Screening Market - AOL
Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe's $3.6 Billion Drug Screening Market and in Middle Eastern Regions - The Manila Times
Revolutionary Fingerprint Drug Test Wins Italian Police Contract, Set to Transform Road Safety - StockTitan
Intelligent Bio Solutions (NASDAQ:INBS) Stock Quotes, Forecast and News Summary - Benzinga
Intelligent Bio Solutions Inc. (NASDAQ:INBS) Short Interest Update - Defense World
Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites - The Manila Times
Intelligent Bio Solutions Expands UK Reach as Princebuild Adopts Revolutionary Fingerprint Drug Test - StockTitan
Intelligent Bio Solutions Releases Positive PK Study Results - MPO-mag
Intelligent Bio Solutions (NASDAQ:INBS) Shares Down 2.1% – Should You Sell? - Defense World
Intelligent Bio Solutions expands share count to over 4.8 million - Investing.com
Intelligent Bio Solutions expands share count to over 4.8 million By Investing.com - Investing.com UK
How maker of drug tests Intelligent Bio Solutions builds its business on people’s tendency to lie - Kursiv Media
Intelligent Bio Solutions Submits FDA Premarket Notification - TipRanks
Intelligent Bio Gains On Applying For Fingerprinting Review - Barchart
Intelligent Bio Gains on Applying for Fingerprinting Review - Baystreet.ca
INBS seeks FDA clearance for fingerprint drug test - Investing.com
Intelligent Bio Solutions Inc. Submits FDA 510(k) Application for Intelligent Fingerprinting Drug Screening System - Nasdaq
Intelligent Bio Solutions Announces 510(k) Submission to US - GlobeNewswire
Intelligent Bio Solutions Files FDA Application for 94% Accurate 10-Minute Drug Screening Breakthrough - StockTitan
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Marketscreener.com
LVIS Corporation Unveils Cloud-Based Platform for EEG Diagnostics - MPO-mag
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - Marketscreener.com
Intelligent Bio Solutions CEO to Discuss FDA Path & Clinical Results in Upcoming Fireside Chat - StockTitan
Intelligent Bio Solutions Releases Business Operations Presentation - TipRanks
Intelligent Bio Solutions completes fingerprint drug screening system study - MSN
Intelligent Bio Solutions Inc (INBS) 財務データ
収益
当期純利益
現金流量
EPS
5.14%
2.09%
大文字化:
|
ボリューム (24 時間):